241 related articles for article (PubMed ID: 28030830)
21. Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.
Wang H; Song C; Gurel Z; Song N; Ma J; Ouyang H; Lai L; Payne KJ; Dovat S
Pediatr Blood Cancer; 2014 Dec; 61(12):2230-5. PubMed ID: 25214003
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.
Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659
[TBL] [Abstract][Full Text] [Related]
23. Ikaros and tumor suppression in acute lymphoblastic leukemia.
Payne KJ; Dovat S
Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
[TBL] [Abstract][Full Text] [Related]
24. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle-specific function of Ikaros in human leukemia.
Li Z; Song C; Ouyang H; Lai L; Payne KJ; Dovat S
Pediatr Blood Cancer; 2012 Jul; 59(1):69-76. PubMed ID: 22106042
[TBL] [Abstract][Full Text] [Related]
26. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.
Bond J; Domaschenz R; Roman-Trufero M; Sabbattini P; Ferreiros-Vidal I; Gerrard G; Asnafi V; Macintyre E; Merkenschlager M; Dillon N
Oncotarget; 2016 Oct; 7(40):65923-65936. PubMed ID: 27588474
[TBL] [Abstract][Full Text] [Related]
27. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.
Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S
Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166
[TBL] [Abstract][Full Text] [Related]
28. Integrated STAT3 and Ikaros Zinc Finger Transcription Factor Activities Regulate Bcl-6 Expression in CD4
Read KA; Powell MD; Baker CE; Sreekumar BK; Ringel-Scaia VM; Bachus H; Martin RE; Cooley ID; Allen IC; Ballesteros-Tato A; Oestreich KJ
J Immunol; 2017 Oct; 199(7):2377-2387. PubMed ID: 28848064
[TBL] [Abstract][Full Text] [Related]
29. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
30. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
[TBL] [Abstract][Full Text] [Related]
32. Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation.
Huang C; Geng H; Boss I; Wang L; Melnick A
Blood; 2014 Feb; 123(7):1012-20. PubMed ID: 24277074
[TBL] [Abstract][Full Text] [Related]
33. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
[TBL] [Abstract][Full Text] [Related]
34. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
35. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
Deucher AM; Qi Z; Yu J; George TI; Etzell JE
Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
[TBL] [Abstract][Full Text] [Related]
36. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
Iacobucci I; Storlazzi CT; Cilloni D; Lonetti A; Ottaviani E; Soverini S; Astolfi A; Chiaretti S; Vitale A; Messa F; Impera L; Baldazzi C; D'Addabbo P; Papayannidis C; Lonoce A; Colarossi S; Vignetti M; Piccaluga PP; Paolini S; Russo D; Pane F; Saglio G; Baccarani M; Foà R; Martinelli G
Blood; 2009 Sep; 114(10):2159-67. PubMed ID: 19589926
[TBL] [Abstract][Full Text] [Related]
37. The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia.
Zhou Y; Lian H; Shen N; Korm S; Kwok Ping Lam A; Layton O; Huiting LN; Li D; Miao K; Zeng A; Landesman-Bollag E; Seldin DC; Fu H; Hong L; Feng H
Haematologica; 2021 May; 106(5):1461-1465. PubMed ID: 32817283
[No Abstract] [Full Text] [Related]
38. Loss-of-function but not dominant-negative intragenic
Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
[TBL] [Abstract][Full Text] [Related]
39. Ikaros, CK2 kinase, and the road to leukemia.
Dovat S; Song C; Payne KJ; Li Z
Mol Cell Biochem; 2011 Oct; 356(1-2):201-7. PubMed ID: 21750978
[TBL] [Abstract][Full Text] [Related]
40. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.
Hu Y; Zhang Z; Kashiwagi M; Yoshida T; Joshi I; Jena N; Somasundaram R; Emmanuel AO; Sigvardsson M; Fitamant J; El-Bardeesy N; Gounari F; Van Etten RA; Georgopoulos K
Genes Dev; 2016 Sep; 30(17):1971-90. PubMed ID: 27664237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
